National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 8,254 cases where Age is Unknown and Vaccine targets COVID-19 (COVID19) and Symptom is Acute endocarditis or Atypical mycobacterium pericarditis or Autoimmune myocarditis or Bacterial pericarditis or Carditis or Endocarditis or Endocarditis bacterial or Endocarditis enterococcal or Endocarditis noninfective or Endocarditis staphylococcal or Endocarditis viral or Eosinophilic myocarditis or Fungal endocarditis or Giant cell myocarditis or Immune-mediated myocarditis or Lupus endocarditis or Lyme carditis or Meningococcal carditis or Myocarditis or Myocarditis bacterial or Myocarditis infectious or Myocarditis septic or Myopericarditis or Pericarditis or Pericarditis constrictive or Pericarditis infective or Pericarditis lupus or Pericarditis meningococcal or Pericarditis rheumatic or Pericarditis tuberculous or Pleuropericarditis or Purulent pericarditis or Streptococcal endocarditis or Subacute endocarditis or Viral myocarditis or Viral pericarditis

Government Disclaimer on use of this data



Case Details

This is page 25 out of 826

Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next


VAERS ID: 971497 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-01
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-01-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ILPFIZER INC2021029918

Write-up: non-severe pancreatitis; This is a spontaneous report from a contactable physician via a Pfizer colleague. A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunisation. The patient''s medical history concomitant medications were not reported. The patient was hospitalized with non-severe pancreatitis on an unspecified date. The event was recovered on unknown date and been released. Lot/batch number has been requested.; Sender''s Comments: Based on the current available information, a possible contributory role of the suspect product BNT162B2 to the development of event pancreatitis cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 990185 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-17
Onset:2020-12-17
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: C-reactive protein, Chest X-ray, Chest discomfort, Chills, Electrocardiogram, Fatigue, Fibrin D dimer, Full blood count, Headache, Liver function test, Middle insomnia, Myalgia, Pericarditis, Pleurisy, Pleuritic pain, SARS-CoV-2 test, Serositis, Troponin
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Systemic lupus erythematosus (narrow), Eosinophilic pneumonia (broad), Depression (excl suicide and self injury) (broad), Chronic kidney disease (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: IBUPROFEN; NAPROXEN; PARACETAMOL
Current Illness: Suspected COVID-19
Preexisting Conditions: Medical History/Concurrent Conditions: Hidradenitis suppurativa; Pain
Allergies:
Diagnostic Lab Data: Test Date: 20201221; Test Name: CXR; Result Unstructured Data: Test Result:normal; Test Date: 20201221; Test Name: CRP; Result Unstructured Data: Test Result:normal; Test Date: 20201221; Test Name: ECG; Result Unstructured Data: Test Result:normal; Test Date: 20201221; Test Name: D-dimer; Test Result: Negative ; Test Date: 20201221; Test Name: Full blood count; Result Unstructured Data: Test Result:normal; Test Date: 20201221; Test Name: liver function tests; Result Unstructured Data: Test Result:normal; Test Date: 20200418; Test Name: COVID-19 test; Test Result: Positive ; Test Date: 20201221; Test Name: troponin; Test Result: Negative
CDC Split Type: GBPFIZER INC2021038961

Write-up: Fatigue aggravated; Myalgia aggravated; possibly serositis of the heart/pericarditis; possibly serositis of the heart/pericarditis; Myalgia aggravated; Chills; Pleuritic pain; Pleurisy; Chest tightness; awaking the patient in the night; Fatigue aggravated; mild headache; This is a spontaneous report received from a contactable physician from the Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-20210109140524. A 26-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 17Dec2020 at SINGLE DOSE for covid-19 immunisation. Medical history included suspected covid-19 from 14Apr2020 and ongoing (COVID-19 disease in April 2020 with longstanding symptoms since then of fatigue, myalgia, post-exertional malaise), hidradenitis suppurativa, pain. Patient was not enrolled in clinical trial. Patient last menstrual period date reported as 31Dec2020. Concomitant medication included ibuprofen (IBUPROFEN) for pain, influenza vaccine (split virion, inactivated) (INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) on Oct2020, naproxen (NAPROXEN) for Pleuritic pain since 05Jan2021, paracetamol (PARACETAMOL) for pain. The patient experienced fatigue aggravated on an unspecified date with outcome of unknown, myalgia aggravated on an unspecified date with outcome of unknown, pleuritic pain on 19Dec2020 with outcome of recovering, pleurisy on 19Dec2020 with outcome of recovering, chest tightness on 19Dec2020 with outcome of not recovered, fatigue aggravated on 18Dec2020 with outcome of not recovered, myalgia aggravated on 25Dec2020 with outcome of not recovered, chills on 19Dec2020 with outcome of recovered on 21Dec2020. The events were serious due to disability, medically significant. Case narrative: On a background of post-covid fatigue, received vaccine on 17Dec2020, with only mild headache that day. From 18th onwards, a worsening of fatigue resulting in absence from work since then, ongoing. On the 19th, right-sided pleuritic pain began behind the right shoulder, severe, stabbing and awaking the patient in the night (worse on inspiration). On 21Dec2020 - attended local ED - negative D-dimer, negative troponin, normal ECG and CXR. Pain has improved over last few weeks but still present with related retrosternal chest tightness and discomfort when breathing. Consulted with a respiratory consultant who has advised that this could be a vaccine reaction leading to pleurisy and possibly serositis of the heart/pericarditis. The event outcome of headache, awaking the patient in the night, possibly serositis of the heart/pericarditis was unknown. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 18Apr2020.Lab data on 21Dec2020 included: Full blood count, liver function tests, CRP, ECG and CXR reported as normal, negative D-dimer, negative troponin. Patient has not tested positive for COVID-19 since having the vaccine. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.


VAERS ID: 993384 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-05
Onset:2021-01-06
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH NOT KNOWN / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Chest pain, Fatigue, Malaise, Myalgia, Pain in extremity, Pericarditis, SARS-CoV-2 test
SMQs:, Rhabdomyolysis/myopathy (broad), Systemic lupus erythematosus (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CLENIL MODULITE; MAGNESIUM; NORTRIPTYLINE; SENNA ACUTIFOLIA
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma (Shielding patient, asthma - well controlled on Clenil 100 2p bd); Bronchiectasis (no cardiac history); Connective tissue disorder; Constipation; Intrauterine contraception; Migraine with aura; Venous thromboembolism ($g10years ago); Comments: Shielding patient, asthma - well controlled on Clenil 100 2p bd, mild bronchiectasis, no cardiac history, past H/O VTE $g10years ago undifferentiated connective tissue disorder recurrent migraine with aura Mireena Coil in situ Patient has not had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Date: 20200919; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021047603

Write-up: Pericarditis; chest pain; sore arm; fatigue; generalised muscle pains; felt unwell- mild and tolerable; This is a spontaneous report received from a contactable physician by Pfizer from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202101181250094600 and the WWID is GB-MHRA-ADR 24608963. A 47-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 at single dose for covid-19 immunisation. Medical history included asthma (shielding patient, asthma - well controlled on Clenil 100 2p bd), mild bronchiectasis (no cardiac history), past H/O VTE ($g10years ago), undifferentiated connective tissue disorder, recurrent migraine with aura, mireena coli in situ and constipation. Concomitant medication included beclometasone dipropionate (CLENIL MODULITE) for asthma, magnesium for migraine, nortriptyline for migraine, senna acutifolia for constipation. The patient previously received 1st dose of BNT162B2 on 15Dec2020 for covid-19 immunisation. The patient experienced pericarditis on 06Jan2021. After 24 hours (06Jan2021) developed sore arm, fatigue, generalised muscle pains, felt unwell- mild and tolerable, these lasted 5 days. However: also developed chest pain which was severe: 9/10 severity, not relieved by Buscopan/Omeprazole/gaviscon/paracetamol. Not worse or better with food/eating. Not related to exertion, worse when recumbent. Pain too severe to lie flat, was only comfortable leaning forwards on supported elbows. no associated SOB, pain was not pleuritic. Felt like a knife radiating from behind the sternum to the back, no spinal pain or tenderness. Temperature 37.5, pulse 95 regular O2 sats 99%. Only relieving factors were: Ibuprofen 400mg which had to be repeated when the Ibuprofen wore off, and leaning forwards. The patient underwent lab tests and procedures which included COVID-19 virus test: no - negative COVID-19 test on 19Sep2020. Patient has not tested positive for COVID-19 since having the vaccine. The outcome of event pericarditis was recovered on 07Jan2021, for the other events was unknown. No follow-up attempts are possible. No further information is expected. Information about lot/batch number cannot be obtained.


VAERS ID: 1010284 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-02
Onset:2021-01-06
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Dyspnoea, Laboratory test, Myocarditis, Troponin
SMQs:, Anaphylactic reaction (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic kidney disease
Allergies:
Diagnostic Lab Data: Test Date: 20210106; Test Name: RFA; Result Unstructured Data: Test Result:elevated; Test Date: 20210106; Test Name: Tn; Result Unstructured Data: Test Result:elevated
CDC Split Type: ESPFIZER INC2021069537

Write-up: Acute myocarditis; dyspnea; This is a spontaneous report from a contactable physician downloaded from the Agency Agency-WEB and received via Regulatory Authority ES-AEMPS-718564. A 74-year-old male patient received first dose of BNT162B2 (COMIRNATY) via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 vaccination. Medical history included severe chronic kidney disease (CKD). Concomitant medications were not reported. The patient experienced acute myocarditis (medically significant) on 06Jan2021. The physician reported that patient was admitted on 06Jan2021 due to dyspnea, with elevated Tn, elevated RFA. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.


VAERS ID: 1012301 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-09
Onset:2021-01-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1848 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Body temperature, C-reactive protein increased, Chest pain, Eosinopenia, Headache, Interleukin level increased, Lymphopenia, Musculoskeletal chest pain, Myalgia, Pericarditis, Pyrexia, Troponin increased, Vaccination site inflammation
SMQs:, Rhabdomyolysis/myopathy (broad), Haematopoietic leukopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Gastroenteritis; Mite allergy; Thrombopenia
Allergies:
Diagnostic Lab Data: Test Date: 20210110; Test Name: body temperature; Result Unstructured Data: Test Result:39.4 Centigrade; Comments: up to 39.4 c; Test Date: 20210112; Test Name: C-reactive protein increased; Result Unstructured Data: Test Result:unknown results; Test Date: 20210112; Test Name: Eosinopenia; Result Unstructured Data: Test Result:unknown results; Test Date: 20210112; Test Name: Interleukin-6 increased; Result Unstructured Data: Test Result:unknown results; Test Date: 20210112; Test Name: Troponin increased; Result Unstructured Data: Test Result:unknown results
CDC Split Type: ITPFIZER INC2021068171

Write-up: High fever (up to 39.4c); High fever (up to 39.4c), myalgia, asthenia, headache, signs of injection site inflammation, retrosternal intercostal pain. Hospitalization from 12 - 14 January 2021 for acute pericarditis.; High fever (up to 39.4c), myalgia, asthenia, headache, signs of injection site inflammation, retrosternal intercostal pain. Hospitalization from 12 - 14 January 2021 for acute pericarditis.; High fever (up to 39.4c), myalgia, asthenia, headache, signs of injection site inflammation, retrosternal intercostal pain. Hospitalization from 12 - 14 January 2021 for acute pericarditis.; signs of injection site inflammation; retrosternal intercostal pain; retrosternal intercostal pain; Lymphocytopenia; High fever (up to 39.4c), myalgia, asthenia, headache, signs of injection site inflammation, retrosternal intercostal pain. Hospitalization from 12 - 14 January 2021 for acute pericarditis.; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authorities WEB regulatory authority IT-MINISAL02-655006. A 33-year-old male patient received first dose of BNT162B2 (COMIRNATY, lot number EL1848, expiry date 30Apr2021) intramuscular on 09Jan2021 17:00 in left shoulder at single dose for COVID-19 prophylaxis. Medical history included mite allergy unknown if ongoing, COVID-19 from 01Mar2020 to 01Apr2020, thrombocytopenia, and gastroenteritis from 14Dec2020 to 25Dec2020. The patient''s concomitant medications were not reported. On 10Jan2021, the patient experienced high fever (up to 39.4 c), myalgia, asthenia, headache, signs of injection site inflammation, retrosternal intercostal pain, lymphocytopenia and acute pericarditis of likely iatrogenic origin after administration of BNT162B2. The patient was hospitalized due to high fever, myalgia, asthenia, headache, signs of injection site inflammation, retrosternal intercostal pain, lymphocytopenia and acute pericarditis from 12Jan2021 to 14Jan2021. The patient underwent lab tests on 12Jan2021 included c-reactive protein increased, eosinopenia, interleukin-6 increased and troponin increased, all with unknown results. The outcome of the events was recovered on 25Jan2021. Sender Comment: Acute pericarditis of probable iatrogenic origin after administration of COMINRATY.


VAERS ID: 1014936 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-08
Onset:2021-01-15
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Arrhythmia, Blood creatinine, Blood potassium, Blood pressure measurement, Blood sodium, Blood test, C-reactive protein, Chest pain, Computerised tomogram, Electrocardiogram, Haemoglobin, Incorrect route of product administration, Investigation, Leukaemia, Myocarditis, N-terminal prohormone brain natriuretic peptide, Troponin, Troponin T
SMQs:, Drug abuse and dependence (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Haematological malignant tumours (narrow), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal cramps (For a long time severe abdominal cramps 1-2x / month)
Allergies:
Diagnostic Lab Data: Test Name: Creatinine; Result Unstructured Data: Test Result:72; Test Name: k; Result Unstructured Data: Test Result:4.0; Test Name: Blood pressure; Result Unstructured Data: Test Result:155/99; Test Name: Na; Result Unstructured Data: Test Result:138; Test Name: blood tests; Result Unstructured Data: Test Result:there is no Troponin T release in blood tests; Test Name: pulmonary embolism-CT; Result Unstructured Data: Test Result:there is no indication of embolization, nor there; Comments: there is no indication of embolization, nor there is any other explanation for chest pain; Test Name: CRP; Result Unstructured Data: Test Result:2; Test Name: ECG; Result Unstructured Data: Test Result:the machine discovered abnormalities; Comments: the sinus rhythm is 66 / min. No old pellicles in use. T-inversions III, aVF, V1, V3, possibly also V4. No changes in the ST segment. Conduction times are normal.; Test Name: ECG; Result Unstructured Data: Test Result:where the situation progressed, now T-inversions I; Comments: where the situation progressed, now T-inversions III, aVF, V1-V4. The ECG is basically is compatible with myocarditis; Test Date: 20210122; Test Name: ECG; Result Unstructured Data: Test Result:unchanged on January; Test Name: Hb; Result Unstructured Data: Test Result:140; Test Name: fibrine d dimer; Result Unstructured Data: Test Result:0.17; Test Name: pp; Result Unstructured Data: Test Result:76 / min; Test Name: Trom; Result Unstructured Data: Test Result:237; Test Name: Leuk; Result Unstructured Data: Test Result:6.3; Test Name: ProBNP; Result Unstructured Data: Test Result:less than 50; Test Name: Troponin; Result Unstructured Data: Test Result:less than 50; Test Name: Troponin T; Result Unstructured Data: Test Result:less than 5
CDC Split Type: FIPFIZER INC2021074191

Write-up: subcutaneous on 08Jan2021 at single dose; stinging, squeezing chest pain in the sternal area; arrhythmia; Myocarditis; This is a spontaneous report from a non-contactable physician downloaded from the Medicines Agency (MA) Regulatory Authority-WEB FI-FIMEA-20210168. A 24-years-old female patient received bnt162b2 (COMIRNATY), subcutaneousob 08Jan2021 at single dose for covid-19 vaccination. The patient was in general good health condition. No underlying diseases identified, no regular medications. No contraceptive pills. No tendency to blood coagulation in the family. Does not smoke. For a long time severe abdominal cramps 1-2x / month, these studied in occupational health, nothing special. No chance of being pregnant according to the patient. Concomitant medications were not reported.The patient experienced myocarditis on 15Jan2021. On 21Jan2021 initial doctor reported on 15Jan2021 internal medicine physician diagnosed myocarditis without previous infectious disease. The symptoms began on 15Jan2021. Doctor''s referral for internal medicine first aid on 15Jan2021. Reason for the referral: T inversions V1-V4, chest pain. To exclude pulmonary embolism. Today while sitting at the computer at work, a sudden stinging, squeezing chest pain in the sternal area. The intense pain lasted a couple of minutes, only relieved while lying down. An ECG was taken, in which the machine discovered abnormalities, and patient was referred for a visit to the emergency room doctor. Upon meeting the patient, the pains were eased. The pain situation did not recur. Breathing was momentarily challenging due to the pain, now calmed down. No nausea, no vomiting. No similar pain in the past. Status: General condition good. Blood pressure 155/99, pp. 76 / min. No shortness of breath, speaks whole sentences. The pains eased at the time of the investigation. Pain cannot be provoked manually . The rotation of the chest and the movements of the upper limbs do not affect the sensation. A steady, regular, silent rhythm in heart auscultation. Pure, symmetrical breathing sounds in lung auscultation. No swelling in the legs, calves without pain. ADP dorsalis pedis artery (palpable symmetrically +/+), posterior tibialis artery (palpable symmetrically +/+). On the ECG, the sinus rhythm is 66 / min. No old pellicles in use. T-inversions III, aVF, V1, V3, possibly also V4. No changes in the ST segment. Conduction times are normal. In blood tests Hb 140, Leuk 6.3, Trom 237. CRP 2. Na 138, K 4.0, Creatinine 72. Troponin <50. fibrine d dimer 0.17. In the follow-up, the pain returns, but to a lesser extent. A little pain feeling constantly. Caused by deep breathing. Another ECG was performed, where the situation progressed, now T-inversions III, aVF, V1-V4. Treatment goal: Called a cardiology emergency, pulmonary embolism should be ruled out. We are doing an emergency referral to internal diseases. Clinical internal medicine physician''s assessment of ECG changes and chest sensation, pulmonary embolism? Text of the Internal Medicine physician 15.1.2021: Daily marking (decursus): In pulmonary embolism-CT, there is no indication of embolization, nor there is any other explanation for chest pain. In blood tests Troponin T less than 5, ProBNP less than 50. Negotiated with a cardiologist, physically active young person. The ECG is basically compatible with myocarditis. However, there is no Troponin T release in blood tests. No need for cardiac ultrasound or rhythm monitoring as a result. Plan was The patient can be released home. Exercise ban for the time being until ECG changes return to normal. After approx. one month, the next cardiac film examination through her own health center at the latest, if then ECG becomes normal, no further ECG checks are required. For symptomatic treatment now Burana as needed by prescription. Agreed with the patient that if the chest pain symptoms worsen at home follow-up or other symptoms appear, then she contacts the emergency room. Estimated that no heavy physical effort at work. Now for the weekend there is no need for sick leave. However, if necessary, the matter can be reconsidered at patient hometown if the symptoms will be still present next week. The patient''s ECG was unchanged on January 22, 2021, and she still had chest pain and arrhythmia. General well-being was good. At that time, I referred the patient again to the internal medicine emergency department. Nothing new was found, UKG was not looked at, but the patient has UKG scheduled within a few weeks. I have consulted with clinic for health and welfare expert doctor and he recommended that Comirnaty booster dose should not be given, until the patient feels good and ECG is normal. The outcome of the event Inappropriate route of vaccination was unknown and was not recovered for the rest events. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.


VAERS ID: 1014995 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-01-19
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Chest pain, Computerised tomogram thorax, Electrocardiogram, Malaise, Myocarditis, Troponin, Troponin increased
SMQs:, Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ADCAL D3; APIXABAN; AZATHIOPRIN; FERROUS FUMARATE; FEXOFENADINE HYDROCHLORIDE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Tubulointerstitial nephritis (Interstitial nephritis - received rituximab in August, which would lower the chance of this being, an antibody driven phenomenon.)
Allergies:
Diagnostic Lab Data: Test Name: CT pulmonary angiogram; Result Unstructured Data: Test Result:ruled out pulmonary embolism; Test Name: Electrocardiogram; Result Unstructured Data: Test Result:showed ST elevation in several leads; Test Name: Troponin; Result Unstructured Data: Test Result:$g2000
CDC Split Type: GBPFIZER INC2021076972

Write-up: Malaise; Chest pain; Troponin increased; Myopericarditis; This is a spontaneous report from a contactable physician received from a regulatory authority. A 32-year-old female patient received 2nd dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 18Jan2021 at single dose for COVID-19 immunization. Medical history included tubulointerstitial nephritis (Interstitial nephritis - received rituximab in August, which would lower the chance of this being, an antibody driven phenomenon). Concomitant medication included calcium carbonate, colecalciferol (ADCAL D3), Apixaban, Azathioprine, Ferrous fumarate, fexofenadine hydrochloride. The patient previously took rituximab for tubulointerstitial nephritis. Patient received 1st dose of BNT162B2 on an unspecified date. The patient experienced myopericarditis on 19Jan2021, malaise on an unspecified date, chest pain, troponin increased. Patient began to feel unwell 12 hours after 2nd dose of Pfizer COVID vaccine. Chest pain then onset and admitted to hospital. Had CT pulmonary angiogram (CTPA), which ruled out pulmonary embolism. Electrocardiogram (ECG) showed ST elevation in several leads and troponin was $g2000. Outcome of myopericarditis was not recovered, of other events was unknown. All events were considered serious due to caused/prolonged hospitalization. No follow-up attempts are possible, information about batch/lot number cannot be obtained.


VAERS ID: 1031453 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-01-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1484 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: C-reactive protein, Chest pain, Chills, Echocardiogram, Electrocardiogram, Myalgia, Myocarditis, Pyrexia, SARS-CoV-2 test, Troponin, White blood cell count
SMQs:, Rhabdomyolysis/myopathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: BUFOMIX EASYHALER; TIBOLONE; MONTELUKAST; ELIQUIS; LEVAXIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma; COVID-19; Hospitalization (in hospital care 4-7th of Dec2020); Hypothyroidism
Allergies:
Diagnostic Lab Data: Test Name: C Reactive Protein; Result Unstructured Data: Test Result:153; Test Name: ultrasound of heart; Result Unstructured Data: Test Result:without remark; Test Name: ECG; Result Unstructured Data: Test Result:general ST segment elevation; Test Date: 20201126; Test Name: SARS-CoV-2 test; Test Result: Positive ; Test Name: troponins; Result Unstructured Data: Test Result:612-11700; Test Name: leukocytes; Result Unstructured Data: Test Result:14.1
CDC Split Type: SEPFIZER INC2021095017

Write-up: Perimyocarditis; fever; chills; myalgia; Respiratory correlated/position correlated chest pain; This is a spontaneous report from contactable physician downloaded from the Regulatory Authority-WEB . A 54-year-old female patient received BNT162B2 (COMIRNATY, lot# EL1484) Intramuscular on 19Jan2021 at single dose for covid-19 immunization. Medical history included asthma, hypothyroidism and Covid positive from 26Nov2020, in hospital care 4-7th of Dec2020. Concomitant medications were budesonide/formoterol fumarate (BUFOMIX EASYHALER), apixaban (ELIQUIS), levothyroxine sodium (LEVAXIN), montelukast, tibolone. The woman developed perimyocarditis on 19Jan2021 with outcome was not recovered. Report assessed as serious, hospitalization. The woman was administered BNT162B2 in the morning and in the afternoon she developed fever, chills and myalgia. Respiratory correlated/position correlated chest pain. According to the reporter ECG shows general ST segment elevation, troponins 612-11700, C Reactive Protein 153, leukocytes 14.1 and ultrasound of heart without remark. Outcome of other events was unknown. No follow-up attempts are possible, information on batch number already obtained.


VAERS ID: 1035204 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-23
Onset:2021-01-24
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0739 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ALFUZOSIN; ATORVASTATIN; FINASTERIDE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Benign prostatic hyperplasia
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021110916

Write-up: Pericarditis; This is a spontaneous report from a contactable other healthcare professional. This is a report received from the Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202102020900004520, Safety Report Unique Identifier GB-MHRA-ADR 24682362. An 83-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EL0739), via an unspecified route of administration on 23Jan2021 at a single dose for COVID-19 immunization. The patient medical history included benign prostatic hyperplasia. Concomitant medication included alfuzosin for benign prostatic hyperplasia (BPH), atorvastatin for cardiovascular risk, finasteride for BPH. The patient experienced pericarditis on 24Jan2021. All the events were considered serious with Seriousness Criteria- Other medically important condition. Patient has not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient is not enrolled in clinical trial. The outcome of event was recovered on an unspecified date in 2021. . No follow up attempts are possible. No further information is expected.


VAERS ID: 1035359 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Myocarditis, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ILPFIZER INC2021123239

Write-up: Myocarditis; Pericarditis; This is a spontaneous report from a contactable consumer. This is the second of 5 cases reported (a few adverse events were reported on Coronavirus vaccine). A 17-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration on an unspecified date single dose for covid-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient experienced myocarditis, pericarditis both on an unspecified date, and was hospitalized on an unknown date. The events outcome was unknown No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : IL-PFIZER INC-2021123240 the same reporter, the same product, the same event, a different patient;IL-PFIZER INC-2021123241 the same reporter, the same product, a different event, a different patient;IL-PFIZER INC-2021123242 the same reporter, the same product, a different event, a different patient;IL-PFIZER INC-2021123238 the same reporter, the same product, a different event, a different patient


Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=25&SYMPTOMS[]=Acute_endocarditis_%2810049001%29&SYMPTOMS[]=Atypical_mycobacterium_pericarditis_%2810055036%29&SYMPTOMS[]=Autoimmune_myocarditis_%2810064539%29&SYMPTOMS[]=Bacterial_pericarditis_%2810004050%29&SYMPTOMS[]=Carditis_%2810062746%29&SYMPTOMS[]=Endocarditis_%2810014665%29&SYMPTOMS[]=Endocarditis_bacterial_%2810014666%29&SYMPTOMS[]=Endocarditis_enterococcal_%2810014671%29&SYMPTOMS[]=Endocarditis_noninfective_%2810062608%29&SYMPTOMS[]=Endocarditis_staphylococcal_%2810014684%29&SYMPTOMS[]=Endocarditis_viral_%2810061837%29&SYMPTOMS[]=Eosinophilic_myocarditis_%2810014961%29&SYMPTOMS[]=Fungal_endocarditis_%2810017529%29&SYMPTOMS[]=Giant_cell_myocarditis_%2810083635%29&SYMPTOMS[]=Immune-mediated_myocarditis_%2810082606%29&SYMPTOMS[]=Lupus_endocarditis_%2810058225%29&SYMPTOMS[]=Lyme_carditis_%2810078417%29&SYMPTOMS[]=Meningococcal_carditis_%2810027270%29&SYMPTOMS[]=Myocarditis_%2810028606%29&SYMPTOMS[]=Myocarditis_bacterial_%2810065218%29&SYMPTOMS[]=Myocarditis_infectious_%2810066857%29&SYMPTOMS[]=Myocarditis_septic_%2810028615%29&SYMPTOMS[]=Myopericarditis_%2810028650%29&SYMPTOMS[]=Pericarditis_%2810034484%29&SYMPTOMS[]=Pericarditis_constrictive_%2810034487%29&SYMPTOMS[]=Pericarditis_infective_%2810062491%29&SYMPTOMS[]=Pericarditis_lupus_%2810058149%29&SYMPTOMS[]=Pericarditis_meningococcal_%2810034492%29&SYMPTOMS[]=Pericarditis_rheumatic_%2810034496%29&SYMPTOMS[]=Pericarditis_tuberculous_%2810055069%29&SYMPTOMS[]=Pleuropericarditis_%2810059361%29&SYMPTOMS[]=Purulent_pericarditis_%2810051071%29&SYMPTOMS[]=Streptococcal_endocarditis_%2810073742%29&SYMPTOMS[]=Subacute_endocarditis_%2810042276%29&SYMPTOMS[]=Viral_myocarditis_%2810047470%29&SYMPTOMS[]=Viral_pericarditis_%2810047472%29&VAX=COVID19&VAXTYPES=COVID-19&WhichAge=range&LOWAGE=(-1)&HIGHAGE=(-1)


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166